Back to Agenda
Regulatory Affairs: Part 5: The NDA – New Drug Application
Session Chair(s)
Elliott Berger, PhD, MS
President
ETB Regualtory Consulting, United States
Regulatory Affairs: Part 5: The NDA – New Drug Application
Have an account?
Already a DIA Member? Sign in. Not a member? Join.
Sign in
Not a Member?
Virtual
Aug 16, 2021 9:00 AM - Aug 20, 2021 1:45 PM
Attend this virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs and NDAs, and the importance of regulatory strategy.
Back to Agenda
President
ETB Regualtory Consulting, United States
Regulatory Affairs: Part 5: The NDA – New Drug Application
Have an account?